Results 141 to 150 of about 16,312 (224)

Drug addiction as a physical disease:The role of physical dependence and other chronic drug-induced neurophysiological changes in compulsive drug self-administration [PDF]

, 1998
Lyvers, Michael
core   +1 more source

Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment.

BMJ, 2010
Kimber J, Copeland L, Hickman M, Macleod J, McKenzie J, De Angelis D, Robertson JR.   +6 more
europepmc   +1 more source

Comparing quality of life methadone and buprenorphine for opioid substitution treatment in Iran. [PDF]

Sci Rep
Nemati A, Raouf-Rahmati A, Serhan H, Mashreghi AR, DadgarMoghaddam M, Hakim HG, Talebi M, Ahmadi R, Niroumand S.   +8 more
europepmc   +1 more source

Iatrogenic withdrawal syndrome in adult intensive care unit: a scoping review. [PDF]

Front Med (Lausanne)
Moisa E, Tuculeanu G, Corneci D, Negoita SI, Bilotta F.   +4 more
europepmc   +1 more source

Research in complex emergencies. Medical Emergency Relief International.

, 2001
Ezard, N
core   +1 more source

ABCB1, SLC22A1, COMT, and OPRM1 genotypes: Study of their influence on plasma methadone levels and clinical response to methadone maintenance treatment in opioid use disorder. [PDF]

Fundam Clin Pharmacol
Ait Tayeb AEK, Laforgue EJ, Schreck B, Grall-Bronnec M, Hardouin JB, Leboucher J, OPAL Group, Victorri-Vigneau C, Verstuyft C.   +8 more
europepmc   +1 more source

Lowering the Threshold. Models of Accessible Methadone and Buprenorphine Treatment [PDF]

, 2010
Keeney, Elizabeth, Saucier, Roxanne
core  

Rapid intravenous symptom-inhibiting fentanyl induction (SIFI) to optimize rotation onto oral opioid agonist therapy among individuals who use unregulated fentanyl: protocol for an open-label, single arm clinical trial. [PDF]

Addict Sci Clin Pract
Azar P, Ignaszewski MJ, Harris M, Barazanci Z, Davison R, Wong JSH, Maharaj A, Mathew N, Hall D, Guillemi SA, Foreman J, Barrios R, Montaner JSG.   +12 more
europepmc   +1 more source

Persisting high rates of mental health disorders in patients in opioid agonist treatment-Results from a 6-year longitudinal study. [PDF]

Am J Addict
Soyka M, Koller G, Hans-Ulrich W, Bühringer G.   +3 more
europepmc   +1 more source